The HIV-1 virion infectivity factor (Vif) targets the cellular cytidine deaminases APOBEC3G (A3G) and APOBEC3F (A3F) for degradation via the host ubiquitin-proteasome pathway. Vif recruits a cellular E3 ubiquitin ligase to polyubiquitinate A3G/F. The activity of Vif critically depends on the cellular core binding factor beta (CBF␤). In this study, we investigated the Vif-CBF␤ interaction and the role of CBF␤ in the E3 ligase assembly. Vif-CBF␤ interaction requires an extensive region of Vif spanning most of its amino terminus and zinc finger region, and cullin 5 (Cul5) binding enhances the stability of the Vif-CBF␤ interaction. Our results further demonstrate that CBF␤ plays a critical role in facilitating Cul5 binding to the Vif/elongin B/elongin C complex. Vif, with or without bound substrate, is unable to bind Cul5 in the absence of CBF␤. These studies support the notion that CBF␤ serves as a molecular chaperone to facilitate Vif-E3 ligase assembly.
T
he cellular cytidine deaminases APOBEC3G (A3G) and APOBEC3F (A3F) are potent viral restriction factors that hypermutate the viral DNA (1-6) and/or physically block reverse transcription (7) (8) (9) . The HIV-1 virion infectivity factor (Vif) overcomes this restriction by targeting A3G/F for degradation via the host ubiquitin-proteasome pathway. Vif specifically interacts with a host E3 ubiquitin ligase complex containing the scaffolding protein cullin 5 (Cul5), the adaptor proteins elongin B (EloB) and elongin C (EloC), and the E2-linking protein Rbx2 (5, (10) (11) (12) (13) . Vif, a 23-kDa protein, assembles the E3 ligase through distinct domains in its C terminus (the Vif C-terminal domain [Vif CTD ]). Vif binds EloC through its BC box region (residues 144 SLQYLA 149 ) (13) (14) (15) (16) , which mimics the conserved cellular interface of SOCS box proteins. The interaction between Vif and Cul5 is primarily mediated by a novel zinc-binding motif (H 108 C 114 C 133 H 139 ) upstream of the Vif BC box (17) (18) (19) (20) (21) .
The interaction between Vif and A3G/F occurs primarily through several nonlinear regions within the N terminus of Vif (the Vif N-terminal domain [Vif NTD ]). While several regions are required for both Vif-A3G and Vif-A3F interactions (22) (23) (24) (25) (26) , some regions of Vif are required only for the interaction with A3G or with A3F (27) . Species specificity for A3G is conferred by 14 DRMR 17 of Vif, while the same region is necessary for Vif-A3F binding but not species differentiation (27) . Degradation of A3G/F is conferred by 21 WXSLVK 26 , 69 YXXL 72 , and 81 LGXGXSI EW 89 ; however, 40 YRHHY 44 is also required for A3G degradation but not A3F degradation (22, 23, 26, 27) . These similarities and differences show the versatility of Vif.
An additional cellular binding partner of Vif, core biding factor beta (CBF␤), is required for Vif-mediated APOBEC3 degradation (28, 29) . CBF␤ forms a heterodimer with RUNX family proteins. These complexes play an essential role in host cell differentiation and development (30, 31) . During an HIV-1 infection, the depletion of CBF␤ results in the inability of Vif to degrade A3G/F (28, 29) and other Vif-sensitive APOBEC3 proteins (32) . This function of CBF␤ is achieved through a direct interaction with Vif, leading to increased Vif stability and solubility, inhibition of Vif oligomerization, and enhancement of Vif binding to Cul5 (33) (34) (35) . The CBF␤-Vif interface involves residues 15 to 126 of CBF␤ (35) (36) (37) .
Additionally, the Vif-CBF␤ interaction may perturb the transcription of RUNX target genes by sequestering CBF␤ away from RUNX proteins (35) .
Despite the established importance of CBF␤ for Vif function, the mechanism by which CBF␤ facilitates Vif-mediated proteasomal degradation of A3G/F is not clear. We carried out biochemical and biophysical studies to determine the role of CBF␤ in the assembly of the Vif/E3 ligase complex. Here, we report that the Vif-CBF␤ interaction requires an extensive region of the Vif N terminus and the zinc finger region and that the addition of Cul5 increases the stability of the Vif/CBF␤ complex. Furthermore, we show that CBF␤ is essential to E3 ligase assembly, as in the absence of CBF␤, Vif does not bind Cul5, thus preventing the assembly of the E3 ligase complex.
conjugated to agarose beads. Harvested cells was resuspended in lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.5% [vol/vol] NP-40, and Complete protease inhibitor cocktail tablets), incubated at 4°C for 30 min, and then centrifuged at 13,000 rpm for 30 min. Cell lysates were mixed with anti-HA antibody-conjugated agarose beads (Roche) and incubated at 4°C for 3 h. Samples were then washed 6 times with washing buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1 mM EDTA, 0.05%[vol/vol] Tween 20). Proteins bound to the beads were eluted with 50 l of elution buffer (0.1 mM glycine-HCl, pH 2.0) or 4ϫ loading buffer containing 0.08 M Tris, pH 6.8, 2.0% SDS, 10% glycerol, 0.1 M dithiothreitol, and 0.2% bromophenol blue. The eluted proteins were subsequently analyzed by Western blotting.
Virus purification, viral infectivity (MAGI) assay, and A3G degradation. For APOBEC3 (A3G or A3F) degradation and viral infectivity assay, HEK293T cells were transfected with 0.5 g of NL4-3⌬Vif, 0.1 g of VR1012, or wild-type or mutant Vif and 0.5 g of A3G-HA in six-well plates. Empty vector VR1012 was used as a negative control. Two days after transfection, cell culture medium was harvested. Empty vector VR1012 was used as a negative control. Cells were reserved for detection of A3G degradation. Virus in cell culture medium was disposed of by centrifugation and filtration through a 0.22-m-pore-size membrane (Millipore). Virus particles were concentrated by ultracentrifugation. The viral pellets resuspended in lysis buffer (phosphate-buffered saline [PBS] containing 1% Triton X-100 and Complete protease inhibitor cocktail [Roche]) were analyzed by Western blotting.
Viral particle infection. MAGI-CCR5 cells were prepared in 24-well plates in 0.5 ml of D-10 cell medium before infection. Cells at 30 to 40% confluence were infected by removing the medium from each well and adding dilutions of virus in a total volume of 500 l of complete DMEM with 20 g of DEAE-dextran per well. After a 2-h infection, 500 l of complete DMEM was added to each well, and the cells were incubated for 48 h at 37°C in a 5% CO 2 incubator. Five hundred microliters of fixing solution (1% formaldehyde, 0.2% glutaraldehyde in PBS) was added after the supernatants were removed. The cells were washed twice with PBS after a 5-min incubation. The staining solution (20 l of 0.2 M potassium ferrocyanide, 20 l of 0.2 M potassium ferricyanide, 2 l of 1 M MgCl 2 , 10 l of 40-mg/ml 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside [XGal]) was added. Cells were incubated for 2 h at 37°C in a non-CO 2 incubator. Staining was stopped by removal of the staining solution, and the cells were thoroughly washed twice with PBS. ␤-Galactosidase activity is under the control of the HIV-1 long terminal repeat promoter, which is trans-activated in this system; blue dots indicate the presence of integrated virus. The number of blue dots was counted, and viral infectivity was determined after normalizing the amount of input virus in terms of the p24 antigen content. All results represent those for infections done in triplicate.
FCS. Fluorescence correlation spectroscopy (FCS) measurements were made on a homebuilt system centered on an inverted IX-71 microscope (Olympus) as previously described (39) . A continuous-emission 488-nm DPSS 50-mW laser (Coherent, Santa Clara, CA) was set to a 5-to 20-mW output power and further adjusted with neutral-density filters to 5 W power just prior to entering the microscope. Fluorescence was collected through the objective and separated from the excitation laser using a Z488rdc long-pass dichroic filter and a HQ600/200m band-pass filter (Chroma, Bellows Falls, VT). Fluorescence was focused onto the aperture of a 50-m optical fiber coupled to an avalanche photodiode (PerkinElmer, Waltham, MA). A digital correlator (Flex03LQ-12; Correlator.com, Bridgewater, NJ) was used to generate the autocorrelation curves. Measurements were made in chambered cover glasses (Nunc, Rochester, NY) that were polyethylene glycol treated to prevent protein adsorption, as described previously (39) . All measurements were at 20.5 Ϯ 0.5°C. Photon traces were collected continuously, and autocorrelation curves were calculated for every 200 s of measurement. The curves were fit, using labwritten software in Matlab, to an equation for two-component diffusion (equation 1), where the diffusion time of each component was fixed on the basis of measurements and fitting of each individual component to an equation for single-component diffusion (equation 2). The diffusion time of free GFP-CBF␤ was calculated from measurements of free purified protein, and the diffusion time of the GFP-CBF␤/MBP-Vif 4-176 /EloBC complex was measured immediately after the complex was separated from free protein by size exclusion chromatography. s accounts for the radialto-axial dimensions of the focal volume and was calculated from fits to free Alexa 488. This allowed us to extract the fraction (F) of GFP-CBF␤ diffusing freely and as part of the GFP-CBF␤/MBP-Vif 4-176 /EloBC complex.
where G(t) is the autocorrelation function, N is the number of molecules, t 1 is the diffusion time of component 1, s accounts for the radial-to-axial dimensions of the focal volume and was calculated from fits to free Alexa 488 dye, and t 2 is the diffusion time of component 2.
RESULTS
Multiple regions in the N terminus of Vif are critical for interaction with CBF␤. Several regions within the Vif N terminus are required for A3G and/or A3F degradation. As the Vif-CBF␤ interaction is essential for A3G/F degradation, we tested whether any of these previously identified regions within Vif are required for Vif-CBF␤ binding (Fig. 1A) . We utilized double-pulldown experiments with 6ϫHis-MBP-Vif constructs and a GST-tagged CBF␤ to assess the ability of the Vif mutants to bind CBF␤ (Fig. 1B ). The Vif mutants tested have various binding affinities for CBF␤. For comparison, we first examined the binding of WT Vif residues 1 to 176 (Vif ) to CBF␤. The WT Vif-CBF␤ interaction was detected using a stringent double-pulldown experiment and was observed as a 1:1 stoichiometric complex, as judged by their band intensities on SDS-PAGE. are critical for the Vif-CBF␤ interaction, while W21 and W38 also play an important role in the interaction (Fig. 1B) . We further inspected the formation of Vif/CBF␤ complexes using chromatographic techniques. We coexpressed 6ϫHis-MBP-tagged WT Vif or its mutants with 6ϫHis-tagged CBF␤ and used Ni-NTA, anion exchange, and size exclusion chromatography to purify the complex (Fig. 1CD) . We also purified MBP-Vif or 6ϫHis-CBF␤ individually as controls. MBP-Vif 1-176 eluted off a size exclusion column at a position corresponding to a large heterogeneous aggregation (Fig. 1C) . CBF␤, as expected, eluted as a monodispersed species at a position corresponding to its molecular mass, 18 kDa (Fig. 1C) . The WT MBP-Vif 1-176 /CBF␤ complex eluted from a size exclusion column as a monodispersed species at a position corresponding to a molecular mass of a 1:1 MBP-Vif/CBF␤ complex (ϳ79 kDa) (Fig. 1C) . Consistent with the double-pulldown assay results, Vif 40 YRHHY 44 /5A also formed a monodispersed, 1:1 complex with CBF␤ ( Fig. 1D) . Small amounts of a Vif 1-176 W21A/W38A/CBF␤ complex were also detected ( Fig. 1D) , confirming that the W21A/W38A mutation significantly reduces but does not abolish Vif-CBF␤ binding, consistent with the results of the double-pulldown experiment.
The mutant Vif constructs that showed severely impaired CBF␤ binding in the pulldown experiment could not be copurified with CBF␤ in vitro. These Vif mutants included Vif EW88AA and Vif 1-176 G84A 86 SIEW 89 /4A. While the MBP-Vif mutants bound the MBP column, 6ϫHis-CBF␤ flowed through (Fig. 1E ). These data confirm that Vif residues G84 86 SIEW 89 are critical for binding to CBF␤. These residues have previously been shown to be essential for HIV infectivity (22) . Our data suggest that the functional importance of these residues may be their role in maintaining the interaction with CBF␤.
Vif residues 5 to 14 are required for CBF␤ binding. We further investigated the importance of the Vif N terminus for interaction with CBF␤. We created Vif N-terminal truncation constructs Vif 4-176 (residues 4 to 176), Vif 5-176 (residues 5 to 176), and Vif (residues 14 to 176) ( Fig. 2A) . We used the double-pulldown and copurification assays described above to test their ability to bind CBF␤. The results from the copurification and pulldown assays showed that Vif 4-176 and Vif 5-176 behave like wildtype Vif and form a monodispersed, 1:1 complex with CBF␤ ( Fig.  2B and C) . In contrast, the results of both assays demonstrated that Vif 14-176 is unable to bind CBF␤ ( Fig. 2C and D) . These results indicate that residues between Vif residue 5 and Vif residue 14 are critical for the Vif-CBF␤ interaction, either by directly participating in the interaction or by playing an important structural role in enabling the interaction from other regions in Vif.
Vif residues 102 to 109 are critical for CBF␤ binding, and the remainder of the zinc finger strengthens the interaction. To fur- ther map the CBF␤-Vif interface, we examined Vif constructs containing C-terminal truncations and mutations (Fig. 3A) . As Vif has been shown to retain the WT capacity for binding to CBF␤ (34), we investigated if the Vif zinc finger domain (residues 100 to 140) is required for the interaction. Our results indicated that the absence of the Vif zinc finger abolishes the Vif-CBF␤ interaction, as little Vif 1-101 was recovered from the double pulldown with CBF␤ (Fig. 3C) . Similarly, Vif 1-101 could not be purified with CBF␤ in vitro, as MBP-Vif 1-101 bound the MBP column and 6ϫHis-CBF␤ flowed through, despite the significant overexpression of CBF␤ (Fig. 3D ). These results demonstrate a requirement for Vif zinc finger residues 100 to 140 for CBF␤ binding. Interestingly, we could purify a small fraction of 6ϫHis-Vif 1-109 and CBF␤ expressed in E. coli as a monodispersed complex eluting off a size exclusion column at a volume corresponding to the molecular mass of the binary complex (ϳ25 kDa) (Fig. 3B) . Furthermore, the results of the double-pulldown experiment showed that Vif 1-109 has an intermediate affinity for CBF␤ that is significantly less than that of wild-type Vif 1-176 but substantially greater than that of Vif (Fig. 3C) . We then investigated what residues in Vif 101-109 are involved in the binding of CBF␤. We again used the double-pulldown experiment to test the ability of two Vif mutants, 102 LAD 104 /ANA and 105 QLI 107 /AAA, to interact with CBF␤. Both triple mutations are detrimental to binding to CBF␤ (Fig.  3C) , confirming the importance of this region in the interaction. Our results provide a potential mechanistic explanation of the previous observation that Vif 105 QLI 107 /AAA abolished HIV-1 infectivity (40).
As discussed above, Vif 1-109 retained the ability to bind CBF␤, but with a reduced affinity compared to that of Vif (Fig. 3C) and Vif (34) . These results indicate that Vif residues 110 to 140 contribute to Vif-CBF␤ binding. This region belongs to a noncanonical zinc finger of Vif (residues 101 to 140) important for Cul5 binding (17) (18) (19) (20) (21) . Thus, we sought to investigate the involvement of two of the zinc coordinating residues of Vif, C114 and C133, in CBF␤ binding in vitro and in cell-based studies (Fig.  4) . The in vitro results show that MBP-Vif C114S and MBP-Vif C133S are able to be copurified with 6ϫHis-CBF␤ (Fig. 4B) . These results indicate that mutation of the two conserved Zn-coordinating cysteines does not abolish CBF␤ binding, consistent with our purification results obtained with the Vif 1-109 /CBF␤ complex (Fig.  3B) . We further used in vivo cell-based studies to assess whether the Zn finger mutations decreased CBF␤'s affinity for Vif. Our coimmunoprecipitation assays showed that Vif C114S and Vif C133A Effects of wild-type Vif and Vif Zn finger mutants on A3G degradation and virion packaging. HEK293T cells were transfected with NL4-3⌬Vif plus A3G in the presence of WT or mutant Vif, as indicated. A3G stability and packaging were assessed by Western blotting. hVif, human Vif. (E) Effect of wild-type Vif and Zn finger mutants on antiviral activity of A3G. HIV-1 strains were produced as described for panel D. Virus infectivity was assessed using MAGI-CCR5 indicator cells, and the virus infectivity in the presence of wild-type Vif was set to 100%. Error bars represent the standard deviations from triplicate wells.
have a slightly impaired ability to bind CBF␤ compared to that of wild-type Vif (Fig. 4C ). This study also assessed the Vif Zn finger mutant's ability to bind Cul5. Consistent with multiple published studies, mutation of Vif C114 and C133 abolished coimmunoprecipitation with Cul5 ( Fig. 4C) (18, 20) . Vif C114S and Vif C133A are defective at degrading A3G (Fig. 4D) , and viruses containing the C114 and C133 Vif mutations are defective in infection (Fig. 4E) . This is all consistent with the notion that a defective Vif-E3 ligase assembly prevents A3G/F degradation. Taken together, our results suggest that the overall zinc finger geometry helps to maintain the Vif-CBF␤ interaction, likely through a critical interface involving Vif residues 102 to 109.
CBF␤ allows the assembly of a Vif-Cul5 E3 ligase. We investigated the role of CBF␤ in the interaction between Vif and Cul5. The inclusion of CBF␤ allows Vif to interact with the E3 ligase complex containing Cul5 and EloBC, enabling the purification of a complex containing all 5 proteins. We first used an N-terminal construct of Cul5 (Cul5 NTD , residues 1 to 384), as it has been established that Cul5 NTD contains all the Vif-interacting elements of the protein (18, 20) . When coexpressed, the Vif 1-154 /EloBC/ Cul5 NTD /CBF␤ complex can be stably purified as a stoichiometric complex (Fig. 5A) . The 5 components elute off an anion exchange column together and can be further purified by gel filtration chromatography (Fig. 5A) . Consistent with this result, our pulldown experiment showed that GST-Cul5 NTD coelutes with Vif 1-176 / EloBC/CBF␤ (Fig. 5A) and Vif 1-154 /EloBC/CBF␤ (data not shown). We also analyzed binding between full-length Cul5/Rbx2 and MBP-Vif 1-176 /EloBC/CBF␤. Consistent with the results obtained with Cul5 NTD , we were able to purify a complex containing all six components, MBP-Vif 1-176 , EloBC, CBF␤, Cul5, and Rbx2 (Fig. 5B) . These results confirm that in the presence of CBF␤, Vif can assemble into the Cul5-containing E3 ligase.
Vif does not assemble into the Cul5-containing E3 ligase in the absence of CBF␤. We next investigated the interaction between Vif and Cul5 in the absence of CBF␤. The results showed that Vif 1-154 , which is able to bind Cul5 in the presence of CBF␤ (Fig. 5A) , does not bind Cul5 without CBF␤ (Fig. 5C ). Vif retained the ability to form a stable complex with EloBC; however, it did not associate with Cul5 NTD (Fig. 5C ) in the absence of CBF␤. Specifically, the Vif 1-154 /EloBC complex clearly separated from Cul5 NTD on an anion exchange column (Fig. 5C) , even though the Vif 1-154 /EloBC subcomplex had good solution behavior and existed in a monomeric, monodispersed form, as shown by size exclusion chromatography (data not shown). We further used GST affinity chromatography to show that GST-Cul5 NTD is unable to pull down Vif 1-154 /EloBC, confirming that a Vif/Cul5 complex is not formed (Fig. 5C) . These data clearly demonstrate that Vif requires CBF␤ to bind Cul5.
The Vif/EloBC/substrate complex cannot bind Cul5 in the absence of CBF␤. We purified a Vif/substrate complex, Vif/ EloBC/A3F CTD , to test the influence of the APOBEC3 substrate on the ability of Vif to interact with Cul5 (Fig. 5D) . We incubated A3F CTD (residues 185 to 373), which contains the Vif-interacting site of A3F, with purified MBP-Vif 4-176 /EloBC/CBF␤ to assemble the substrate complex of Vif in vitro. Interestingly, this allowed us to purify a monodispersed MBP-Vif 4-176 /EloBC/A3F CTD complex to homogeneity (Fig. 5D) , however, without CBF␤. To test the binding of this Vif/substrate complex to Cul5, we also purified Cul5 NTD alone to homogeneity as a monodispersed species (Fig. 5D) .
The Vif/substrate complex without CBF␤ did not assemble with Cul5 in vitro (Fig. 5D ). We incubated the purified MBPVif 4-176 /EloBC/A3F CTD complex with Cul5 NTD and examined their interaction using size exclusion chromatography. No interaction was detected, as MBP-Vif 4 -176 /EloBC/A3F CTD and Cul5 NTD eluted as two distinct peaks off the size exclusion column at positions corresponding to those of the two individual inputs before mixing (Fig. 5D ). This result suggests that in the absence of CBF␤, even if a Vif/substrate complex is formed, it is unable to assemble with Cul5.
The C-terminal half of Vif (Vif CTD ) associates with Cul5 in the absence of CBF␤. Interestingly, our data, as well as others, clearly show that the C-terminal half of Vif (Vif CTD ) can assemble with Cul5 in the absence of CBF␤ (18, 41) . When C-terminal Vif constructs (residues 100 to 154) were coexpressed with E3 ligase components EloBC and Cul5 NTD , a monodispersed, monomeric complex containing all four proteins could be purified (Fig. 6) (41) . It has been demonstrated previously that the affinity between Vif CTD / EloBC and Cul5 is ϳ90 nM, whereas the affinity between EloBC and Cul5 is ϳ7 M (33, 35, 41) . The interaction between EloBC and Cul5 is significantly weaker than that between Vif CTD /EloBC and Cul5, indicating that Vif CTD is responsible for the majority of the Vif CTD / EloBC interaction with Cul5 (41) . This, together with the observation that full-length Vif cannot bind Cul5 without CBF␤ (Fig. 5CD) , suggests that the N terminus of Vif prevents the binding of Cul5 to Vif and that the addition of CBF␤ relieves this Vif N-terminal inhibition.
The addition of Cul5 stabilizes the CBF␤-Vif interaction in vitro. The lack of a Vif/substrate/CBF␤ complex in the experiment described above prompted us to investigate the stability of the Vif-CBF␤ interaction in vitro. We used fluorescence correlation spectroscopy (FCS) and size exclusion chromatography to analyze the dissociation of CBF␤ from the remainder of the Vif/EloBC/ CBF␤ complex. FCS measures fluctuations in intensity arising from diffusion of fluorescent molecules through an experimental observation volume (focal volume) (Fig. 7A) . The transit time of the molecules reflects their size; smaller molecules diffuse more rapidly, while larger molecules diffuse more slowly. It is therefore a powerful technique to detect the formation or dissociation of molecular complexes. Here we used FCS to observe the dissociation of CBF␤ tagged with GFP from the GFP-CBF␤/MBP-Vif 4-176 / EloBC complex over time. At the initial time point, all the GFP-CBF␤ was bound to Vif/EloBC, reflected by a long diffusion time. Over time, the average diffusion time of the sample decreased, reflecting contributions both from the GFP-CBF␤/MBP-Vif 4-176 / EloBC complex and from free GFP-CBF␤, which diffused much more rapidly. Over 5 h, more than 40% of the starting complex dissociated to free GFP-CBF␤ and MBP-Vif/EloBC (Fig. 7A) . Consistent with this observation, our size exclusion chromatography analysis showed the breakdown of the majority of the complex in 1 to 2 days at room temperature (Fig. 7B) .
The addition of Cul5 and Rbx2 to Vif/EloBC/CBF␤ resulted in a significantly more stable complex in vitro. We monitored the dissociation of the purified MBP-Vif 4-176 /EloBC/CBF␤/Cul5/ Rbx2 complex using size exclusion chromatography. In contrast to the observation presented above, the results showed a much more stable complex, with a significant fraction remaining intact even after 1 week at room temperature (Fig. 7C) . These observations are consistent with those of a study that found that Vif/ EloBC/CBF␤/Cul5/Rbx2 is less prone to precipitation than the Vif/EloBC/CBF␤ complex (34) . These in vitro stability tests on purified complexes suggest that the Vif-CBF␤ interaction may be intrinsically unstable and that it can be enhanced by the E3 ligase scaffolding protein Cul5.
DISCUSSION
It has recently been established that CBF␤ plays a critical role in Vif-mediated A3G/F degradation. However, the mechanisms by which CBF␤ facilitates A3G/F depletion remain unclear. The studies described herein provide important information about the function of CBF␤ in E3 ligase assembly as well as details of the Vif-CBF␤ interaction interface. In particular, multiple regions of Vif are known to be important to Vif function, but the mechanisms are unclear. Our comprehensive Vif-CBF␤ interface mapping results help to delineate the role of various Vif regions and provide a detailed biochemical foundation for understanding how Vif interacts with CBF␤. Furthermore, our studies on Vif-Cul5 E3 ligase assembly reveal an important potential mechanism of CBF␤ that has not been shown before, namely, that it serves as a molecular chaperone to shape Vif in the appropriate conformation to interact with Cul5.
Our mapping studies showed that Vif interacts with CBF␤ using an extended interface encompassing most of the viral protein which overlaps with regions implicated in its interaction with other cellular binding partners (Fig. 8A) . Regions in the N terminus of Vif are known to be the interaction sites for the A3G/F proteins. Two of these regions were also found to be essential for CBF␤ binding in our experiments. For example, 84 GXSIEW 89 was critical for the Vif-CBF␤ interaction (Fig. 1B and E) , consistent with in vivo data illustrating that the mutation of 86 SIEW 89 inhibited A3G/F degradation (22) . Similarly, mutation of Vif residues W21/W38 significantly reduced the affinity for CBF␤ (Fig. 1B and  D) , consistent with in vivo studies showing that these residues are important for the interaction with CBF␤ (29) and the degradation of A3G/F (23, 25) . It is likely that the importance of these Vif regions in APOBEC3 degradation is due to their roles in the Vif-CBF␤ interaction, rather than for Vif A3G/F binding. On the other hand, our studies showed that Vif residues 40 YRHHY 44 are not involved in the Vif-CBF␤ interaction, despite their established role in A3G degradation (Fig. 1B and D) (27) , indicating that these residues compose a bona fide A3G interaction site. Therefore, our mapping studies help to delineate the specific roles of Vif residues in viral evasion of the APOBEC3 proteins.
Besides the essential N-terminal regions, the C-terminal zinc finger region of Vif is also important for CBF␤ binding. Specifically, the first 8 residues of the zinc finger region (residues 102 to 109) are critical for interaction with CBF␤, while the remainder of the zinc finger (residues 110 to 140) also contributes to the Vif-CBF␤ interaction (Fig. 3) . Previous studies showed that the first 140 residues of Vif can interact with CBF␤ (34). Our study further shows that deletion of the zinc finger domain prevents the reconstitution of the Vif/CBF␤ complex in vitro (Fig. 3CD) . The addition of residues at the beginning of the zinc finger domain (residues 102 to 109) allowed the purification of Vif/CBF␤, albeit with a reduced affinity compared to that of Vif with an intact zinc finger (Fig. 3BC) . In vivo coimmunoprecipitation studies showed that mutation of the two critical Vif Zn finger residues (C114/C133) slightly decreased CBF␤ binding to Vif (Fig. 4C) . These experiments indicate that the zinc finger domain of Vif is involved in CBF␤ binding, with residues 102 to 109 playing a critical role.
Our experiments demonstrate that CBF␤ is required for the assembly of the Vif/EloBC/Cul5 E3 ligase, specifically, for Cul5 binding to Vif (Fig. 5AB) . In the absence of CBF␤, full-length Vif is able to assemble with the adaptor proteins EloBC but is unable to bind Cul5 (Fig. 5C) . Interestingly, the C terminus of Vif is capable of binding both EloBC and Cul5 (Fig. 6 ). This suggests that in the absence of CBF␤, Vif NTD likely adopts a conformation preventing Cul5 association and that the binding of CBF␤ alters the Vif structure to prime it for Cul5 binding. These observations are consistent with in vivo studies demonstrating that silencing CBF␤ inhibits the interaction between Vif and Cul5 (29) and that mutation in Vif 86 SIEW 89 , a region critical for CBF␤ association ( Fig. 1B and E) , eliminates Cul5 binding (22) . CBF␤ presumably enables both Vif NTD and Vif CTD to participate in the interaction with Cul5. This is in agreement with studies that show that in the presence of CBF␤, full-length Vif has an affinity to Cul5 (33, 35) higher than that provided by Vif CTD (41) . These results support the notion that CBF␤ serves as a molecular chaperone, enabling Vif to assemble the Cul5-containing E3 ubiquitin ligase (Fig. 8B) .
Taken together, the extensive interaction between Vif and CBF␤ may serve to increase the solubility and stability of Vif, as well as to shape the viral protein in a conformation that facilitates the assembly of the Cul5-containing E3 ubiquitin ligase. The fully assembled Vif/EloBC/CBF␤/Cul5/Rbx2 E3 ligase exhibits further increased stability in comparison to that of its constituents without Cul5. Significant data from other studies and our studies have ruled out a direct interaction between Cul5 and CBF␤ (28, 29, 33) ; thus, the added stability is likely a result of Cul5 stabilizing Vif. It has been proposed that CBF␤ functions to stabilize Vif in vivo (28, 35) . Our study demonstrates that, in addition to this stabilization role, CBF␤ has a more fundamental function in serving as a molecular chaperone that enables the formation of the Vif/Cul5 complex essential for A3G/F degradation, albeit the complex further enhances the stability of Vif.
